Shell Asset Management CO Collegium Pharmaceutical, Inc Transaction History

Shell Asset Management CO

$2.9 Billion
Q2 2025

A detailed history of Shell Asset Management CO transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Shell Asset Management CO holds 5,158 shares of COLL stock, worth $163,921. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,158

Previous 6,402 19.43%

Holding current value

$163,921

Previous $191,000 19.9%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$24.67 - $30.44 $30,689 - $37,867	-1,244 Reduced 19.43%	5,158 $153,000
Q1 2025 May 14, 2025	SELL	$28.04 - $33.91 $4,458 - $5,391	-159 Reduced 2.42%	6,402 $191,000
Q3 2024 Nov 07, 2024	SELL	$31.4 - $39.07 $11,586 - $14,416	-369 Reduced 5.32%	6,561 $254,000
Q1 2024 Jul 31, 2024	SELL	$31.23 - $40.91 $13,647 - $17,877	-437 Reduced 5.93%	6,930 $223,000
Q1 2024 May 14, 2024	SELL	$31.23 - $40.91 $8,900 - $11,659	-285 Reduced 3.72%	7,367 $286,000
Q4 2023 Feb 14, 2024	SELL	$21.16 - $30.8 $49,239 - $71,671	-2,327 Reduced 23.32%	7,652 $236,000
Q3 2023 Nov 08, 2023	SELL	$21.23 - $24.28 $3,311 - $3,787	-156 Reduced 1.54%	9,979 $223,000
Q2 2023 Jul 28, 2023	SELL	$21.06 - $24.0 $1,179 - $1,344	-56 Reduced 0.55%	10,135 $218,000
Q1 2023 May 15, 2023	SELL	$23.0 - $29.88 $828 - $1,075	-36 Reduced 0.35%	10,191 $244,000
Q4 2022 Feb 07, 2023	SELL	$16.14 - $23.55 $33,668 - $49,125	-2,086 Reduced 16.94%	10,227 $237,000
Q3 2022 Nov 14, 2022	SELL	$15.46 - $20.1 $50,105 - $65,144	-3,241 Reduced 20.84%	12,313 $197,000
Q2 2022 Aug 09, 2022	BUY	$14.22 - $20.88 $87,040 - $127,806	6,121 Added 64.89%	15,554 $276,000
Q1 2022 May 04, 2022	SELL	$17.2 - $22.5 $23,994 - $31,387	-1,395 Reduced 12.88%	9,433 $192,000
Q4 2021 Feb 09, 2022	BUY	$17.5 - $21.35 $892 - $1,088	51 Added 0.47%	10,828 $202,000
Q3 2021 Nov 04, 2021	SELL	$17.75 - $25.39 $8,165 - $11,679	-460 Reduced 4.09%	10,777 $213,000
Q2 2021 Aug 12, 2021	BUY	$21.74 - $25.28 $153,049 - $177,971	7,040 Added 167.74%	11,237 $266,000
Q1 2021 May 10, 2021	BUY	$19.25 - $26.1 $80,792 - $109,541	4,197 New	4,197 $99,000

Others Institutions Holding COLL

# of Institutions

256

Shares Held

37.2M

Call Options Held

61.1K

Put Options Held

5.8K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.08B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Collegium Pharmaceutical, Inc Transaction History